Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial.

Bastiaan T van DijkSytske Anne BergstraJ Merlijn van den BergDieneke Schonenberg-MeinemaLisette W A van Suijlekom-SmitMarion A J van RossumYvonne Koopman-KeeminkRebecca Ten CateCornelia F AllaartDaniëlle M C BrinkmanPetra C E Hissink Muller

Published in: Pediatric rheumatology online journal (2024)

Dutch Trial Register; NTR1574; 3 December 2008; https://onderzoekmetmensen.nl/en/trial/26585 .

Keyphrases

juvenile idiopathic arthritis
clinical trial
study protocol
phase ii
phase iii
open label
double blind
disease activity
randomized controlled trial
placebo controlled
rheumatoid arthritis
rheumatoid arthritis patients
ankylosing spondylitis